La tecnología surgida de la transformación digital ha traído consigo cambios en la asistencia sanitaria. En los próximos años, la Telefarmacia previsiblemente  se convertirá en uno de los aspectos más importantes de la Telemedicina, ya  que ofrece a los pacientes un acceso más inmediato a la atención  farmacéutica, supone una reducción de costes tanto para los pacientes como  para los sistemas sanitarios, y deriva en una mayor satisfacción, experiencia y  comodidad de los pacientes, mejorando así los resultados clínicos. Debido en  gran medida a la pandemia de COVID‑19, la Telefarmacia ha adquirido gran  importancia en el ámbito de la atención farmacéutica, ya que esta crisis ha  provocado una enorme presión sobre los sistemas sanitarios de todo el mundo. Se pueden encontrar multitud de experiencias publicadas en la literatura  científica sobre modelos de Telefarmacia en diferentes países del mundo.  Existen algunos modelos innovadores de servicios de Telefarmacia orientados a  optimizar y mejorar el acceso a la atención farmacéutica, lo que se traduce  en una mejora de la seguridad y los resultados de los pacientes. Entre las  ventajas de la Telefarmacia se incluye el aumento del valor para las farmacias  y los farmacéuticos y la adaptación a las necesidades de los pacientes, la mejora de la atención interprofesional, el aumento de la eficiencia de los  sistemas sanitarios y la mayor prestación de servicios centrados en el paciente, entre otras. Sin embargo, a pesar de presentar múltiples ventajas, siguen  existiendo importantes barreras para la implantación de la Telefarmacia, como  la confidencialidad del paciente y la privacidad de la información clínica. Estas  barreras para la implantación de la Telefarmacia pueden dividirse en cuatro  ámbitos: tecnológico, organizativo, humano y económico. La prestación de  atención y servicios farmacéuticos a través de medios digitales es una  prioridad clave de la Federación Internacional Farmacéutica. La salud digital es  uno de los 21 Objetivos de Desarrollo lanzados por la Federación Internacional  Farmacéutica en 2020. El informe de la Federación Internacional Farmacéutica  sobre salud digital en la formación farmacéutica en 2021 describe la  preparación, adaptabilidad y capacidad de respuesta de la formación  farmacéutica y las necesidades de conocimientos y habilidades de los  farmacéuticos sobre la salud digital. Entre otras herramientas de salud digital,  la Telemedicina/Telefarmacia ha sido señalada como una de las herramientas  preferidas por los encuestados para formar y aprender.

EXPH (EXpert Panel on effective ways of investing in Health). Assessing the impact of digital transformation of health services. 2018:107 [web page]. European Commission. 2019 [02/20/2022, 22/20/2022]. Available at: https://ec.europa.eu/health/system/files/2019-11/022_digitaltransformation_en_0.pdf

European Commission. Horizon Europe, Work Programme 2021-2022 Vol. 4 [web page]. European Commission. 2021. [02/19/2022, 02/19/2022]. Available at: https://ec.europa.eu/info/funding- tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp- 4-health_horizon-2021-2022_en.pdf

Poudel A, Nissen LM. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integr Pharm Res Pract. 2016;5:75- 82. DOI: 10.2147/IPRP.S101685

Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm. 1999;56(14):1405-26. DOI: 10.1093/ajhp/56.14.1405

Friesner D, Scott DM. Exploring the formation of patient satisfaction in rural community telepharmacies. J Am Pharm Assoc (2003). 2009;49(4):509-18. DOI: 10.1331/JAPhA.2009.08110

Win AZ. Telepharmacy: Time to pick up the line. Res Social Adm Pharm. 2017;13(4):882-3. DOI: 10.1016/j.sapharm.2015.06.002

Angaran DM. Telemedicine and telepharmacy: Current status and future implications. Am J Health Syst Pharm. 1999;56(14):1405-26. DOI: 10.1093/ajhp/56.14.1405

Hedima EW, Okoro RN. Telepharmacy: An opportunity for community pharmacists during the COVID-19 pandemic in Sub Saharan Africa. Health Policy Technol. 2021;10(1):23-4. DOI: 10.1016/j.hlpt.2020.10.013

Killeen RM, Grindrod K, Ong SW. Innovations in practice: Telepharmacy’s time has arrived. Can Pharm J (Ott). 2020;153(5):252- 5. DOI: 10.1177/1715163520945732

Elbeddini A, Yeats A. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract. 2020;13:23. DOI: 10.1186/s40545- 020-00229-z

Unni EJ, Patel K, Beazer IR, Hung M. Telepharmacy during COVID- 19: A Scoping Review. Pharmacy (Basel). 2021;9(4). DOI: 10.3390/pharmacy9040183

Sociedad Española de Farmacia Hospitalaria. Biblioteca. Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: Recommendations for its implementation and development. 2020 [consultado 10/20/2022]. Disponible en: https://www.sefh.es/bibliotecavirtual/posicionamientos_institucionales/1 2-POSICIONAMIENTO_TELEFARMACIA_20200510.pdf

United States Congress. H.R.6074-Coronavirus Preparedness and Response Supplemental Appropriations Act. [web page]. USA congress. 2020 [02/10/2022, 02/10/2022] Available at: https://www.congress.gov/bill/116th-congress/house-bill/6074/titles

Australian Pharmacist. 2020. Medication reviews via telehealth to better protect Australians [web page]. Pharmaceutical Society of Australia. 2020 [02/19/2022, 02/19/2022]. Available at: https://www.psa.org.au/medication-reviews-viatelehealth-to-better- protect-australians/

Shafiee Hanjani L, Bell JS, Freeman C. Undertaking medication review by telehealth. Aust J Gen Pract. 2020;49(12):826-31. DOI: 10.31128/ajgp-06-20-5461

McFarland R. Telepharmacy for remote hospital inpatients in north- west Queensland. J Telemed Telecare. 2017;23(10):861-5. DOI: 10.1177/1357633x17732367

Mohiuddin AK. Prospect of tele-pharmacists in COVID-19 pandemic situation in Bangladesh. J Biosci Biomed. 2020;1. DOI: 10.36502/2020/hcr.6164

Ramos JGR, Hernandes SC, Pereira TTT, Oliveira S, Soares DM, Passos RDH, et al. Differential impact of on-site or telepharmacy in the intensive care unit: a controlled before-after study. Int J Qual Health Care. 2021;33(1):mzab011. DOI: 10.1093/intqhc/mzab011

Newman P, Dhaliwall S, Polyakova O, McDonald K. Pharmacy Distribution, Clinical, and Management Services: A Survey of Small Hospitals in Canada Supported by Telepharmacy Services. Can J Hosp Pharm. 2021;74(3):256-68. DOI: 10.4212/cjhp.v74i3.3153

Marchese M, Heintzman A, Pasetka M, Charbonneau F, DeAngelis C, Peragine C. Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic. J Oncol Pharm Pract. 2021;27(3):650-7. DOI: 10.1177/1078155221991202

Li H, Zheng S, Li D, Jiang D, Liu F, Guo W, et al. The Establishment and Practice of Pharmacy Care Service Based on Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic. Front Pharmacol. 2021;12:707442. DOI: 10.3389/fphar.2021.707442

Amkreutz J, Lenssen R, Marx G, Deisz R, Eisert A. Medication safety in a German telemedicine centre: Implementation of a telepharmaceutical expert consultation in addition to existing tele- intensive care unit services. J Telemed Telecare. 2020;26(1‑2):105-12. DOI: 10.1177/1357633x18799796

Ameri A, Salmanizadeh F, Keshvardoost S, Bahaadinbeigy K. Investigating Pharmacists’ Views on Telepharmacy: Prioritizing Key Relationships, Barriers, and Benefits. J Pharm Technol. 2020;36(5):171- 8. DOI: 10.1177/8755122520931442

Baldoni S, Pallotta G, Traini E, Sagaro GG, Nittari G, Amenta F. A survey on feasibility of telehealth services among young Italian pharmacists. Pharm Pract (Granada).2020;18(3):1926-1926. DOI: 10.18549/PharmPract.2020.3.1926

Matsumoto Y, Kizaki H, Ikeda Y, Nakamura S, Kina S, Nagai T, et al. Telepharmacy in mountainous depopulated areas of Japan: an exploratory interview study of patients’ perspectives. Drug Discov Ther. 2022;15(6):337-40. DOI: 10.5582/ddt.2021.01102

Muflih SM, Al-Azzam S, Abuhammad S, Jaradat SK, Karasneh R, Shawaqfeh MS. Pharmacists’ experience, competence and perception of telepharmacy technology in response to COVID-19. Int J Clin Pract. 2021;75(7):e14209. DOI: 10.1111/ijcp.14209

Koster ES, Philbert D, Bouvy ML. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm. 2021;17(1):2002-4. DOI: 10.1016/j.sapharm.2020.07.001

Mahdi SS, Allana R, Battineni G, Khalid T, Agha D, Khawaja M, et al. The promise of telemedicine in Pakistan: A systematic review. Health Sci Rep. 2022;5(1):e438. DOI: 10.1002/hsr2.438

Bukhari N, Siddique M, Bilal N, Javed S, Moosvi A, Babar ZU. Pharmacists and telemedicine: an innovative model fulfilling Sustainable Development Goals (SDGs). J Pharm Policy Pract. 2021;14(1):96. DOI: 10.1186/s40545-021-00378-9

Plantado ANR, De Guzman HJ, Mariano JEC, Salvan MRAR, Benosa CAC, Robles YR. Development of an Online Telepharmacy Service in the Philippines and Analysis of Its Usage During the COVID-19 Pandemic. J Pharm Pract. 2021;0(0):08971900211033120. DOI: 10.1177/08971900211033120

Al Ammari M, AlThiab K, AlJohani M, Sultana K, Maklhafi N, AlOnazi H, et al. Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes. Front Pharmacol. 2021;12:652482. DOI: 10.3389/fphar.2021.652482

Asseri A, Mohamed M, Yasin I, Moustafa MM, Roubie FM, El-Anssasy SM, et al. Implementation and evaluation of telepharmacy during COVID-19 pandemic in an academic medical city in the Kingdom of Saudi Arabia: paving the way for telepharmacy. World J Adv Res Rev. 2020;7:218-26. DOI: 10.30574/wjarr.2020.7.2.0250

Margusino-Framiñán L, Fernández-Llamazares CM, Negro-Vega E, Tortajada-Goitia B, Lizeaga G, Mercadal-Orfila G, et al. Outpatients’ Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project. J Multidiscip Healthc. 2021;14:3621-32. DOI: 10.2147/JMDH.S343528

Peláez Bejarano A, Villar Santos P, Robustillo-Cortés MA, Sánchez Gómez E, Santos Rubio MD. Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm. 2021;28(e1):e120-3. DOI: 10.1136/ejhpharm-2020-002500

Kulatunga G, Hewapathirana R, Marasinghe R, Dissanayake V. A review of Telehealth practices in Sri Lanka in the context of the COVID- 19 pandemic. Sri Lanka Journal of Bio-Medical Informatics. 2020;11:8. DOI: 10.4038/sljbmi.v11i1.8090

Mohamed Ibrahim O, Ibrahim RM, Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N. Evaluation of Telepharmacy Services in Light of COVID-19. Telemed J E Health. 2021;27(6):649-56. DOI: 10.1089/tmj.2020.0283

Manuel FC, Wieruszewski ED, Brown CS, Russi CS, Mattson AE. Description of telepharmacy services by emergency medicine pharmacists. Am J Health Syst Pharm. 2022 ;79(11):873-80. DOI: 10.1093/ajhp/zxac027

Hefti E, Wei B, Engelen K. Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic. Telemed J E Health. 2022. DOI: 10.1089/tmj.2021.0420

Ho I, Nielsen L, Jacobsgaard H, Salmasi H, Pottegård A. Chat-based telepharmacy in Denmark: design and early results. Int J Pharm Pract. 2015;23(1):61-6. DOI: 10.1111/ijpp.12109

Inch J, Notman F, Watson M, Green D, Baird R, Ferguson J, et al. Tele-pharmacy in rural Scotland: a proof of concept study. Int J Pharm Pract. 2017;25(3):210-9. DOI: 10.1111/ijpp.12376

Erni P, Von Overbeck J, Reich O, Ruggli M. netCare, a new collaborative primary health care service based in Swiss community pharmacies. Res Social Adm Pharm. 2016;12(4):622-6. DOI: 10.1016/j.sapharm.2015.08.010

Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. Res Social Adm Pharm. 2018;14(8):707-17. DOI: 10.1016/j.sapharm.2017.10.011

Schneider PJ. Evaluating the impact of telepharmacy. Am J Health Syst Pharm. 2013;70(23):2130-5. DOI: 10.2146/ajhp130138

Van Dyk L. A review of telehealth service implementation frameworks. Int J Environ Res Public Health. 2014;11(2):1279-98. DOI: 10.3390/ijerph110201279

Roig F, Saigí F. [Barriers to the normalization of telemedicine in a healthcare system model based on purchasing of healthcare services using providers’ contracts]. Gac Sanit. 2011;25(5):397-402. DOI: 10.1016/j.gaceta.2011.01.004

Sociedad Española de Farmacia Hospitalaria. Biblioteca. Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: Recommendations for its implementation and development. 2020 [accessed 10/ 20/2022]. Available at: https://www.sefh.es/bibliotecavirtual/posicionamientos_institucionales/1 2-POSICIONAMIENTO_TELEFARMACIA_20200510.pdf

Ashiru-Oredope D, Chan AHY, Olaoye O, Rutter V, Babar ZU; C. P. A. COVID-19 Action Team. Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries. J Pharm Policy Pract. 2020;13(1):72. DOI: 10.1186/s40545-020-00275-7

Steckler T. Telepharmacy: Controversy and Promise. J Pharm Technol. 2016;32. DOI: 10.1177/8755122516670415

Grigsby WJ. Telehealth: an assessment of growth and distribution. J Rural Health. 2002;18(2):348-58. DOI: 10.1111/j.1748- 0361.2002.tb00896.x

Yemm KE, Arnall JR, Cowgill NA. Necessity of pharmacist-driven nonprescription telehealth consult services in the era of COVID-19. Am J Health Syst Pharm. 2020;77(15):1188. DOI: 10.1093/ajhp/zxaa162

Heslin MJ, Liles JS, Moctezuma-Velázquez P. The use of telemedicine in the preoperative management of pheochromocytoma saves resources. Mhealth. 2019;5:27. DOI: 10.21037/mhealth.2019.08.04

Feltner C, Jones CD, Cené CW, Zheng ZJ, Sueta CA, Coker- Schwimmer EJ, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2014;160(11):774-84. DOI: 10.7326/m14-0083

Davis TM, Barden C, Dean S, Gavish A, Goliash I, Goran S, et al. American Telemedicine Association Guidelines for TeleICU Operations. Telemed J E Health. 2016;22(12):971-80. DOI: 10.1089/tmj.2016.0065

Schnur ES, Adams AJ, Klepser DG, Doucette WR, Scott DM. PCMHs, ACOs, and medication management: lessons learned from early research partnerships. J Manag Care Pharm. 2014;20(2):201-5. DOI: 10.18553/jmcp.2014.20.2.201

Sankaranarayanan J, Murante LJ, Moffett LM. A retrospective evaluation of remote pharmacist interventions in a telepharmacy service model using a conceptual framework. Telemed J E Health. 2014;20(10):893-901. DOI: 10.1089/tmj.2013.0362

Strnad K, Shoulders BR, Smithburger PL, Kane-Gill SL. A Systematic Review of ICU and Non-ICU Clinical Pharmacy Services Using Telepharmacy. Ann Pharmacother. 2018;52(12):1250-8. DOI: 10.1177/1060028018787213

Pan American Health Organization. Framework for the Implementation of a Telemedicine Service [web page]. Washington, DC: PAHO; 2016 [Date consulted, 02/18/2022]. Available at: https://iris.paho.org/bitstream/handle/10665.2/28414/9789275119037 _eng.pdf?sequence=6&isAllowed=y

International Pharmaceutical Federation (FIP). FIP Development Goals - 20 [web page]. The Hague; 2022 [Date consulted, 02/23/2022]. Available at: https://developmentgoals.fip.org/dg20/

International Pharmaceutical Federation (FIP). FIP Digital health in pharmacy education [web page]. The Hague; 2021 [Date consulted, 02/23/2022]. Available at: https://www.fip.org/file/4958

International Pharmaceutical Federation (FIP). FIP train the trainer online course for educators on digital health [web page]. The Hague; 2021 [Date consulted, 02/17/2022]. Available at: https://www.fip.org/fip-global-platform